STAG2 and melanoma: Knockdown of STAG2 in melanoma cells did not apparently affect cell cycle progression, apoptosis, or growth of xenograft tumors in nude mice, but significantly decreased the sensitivities of melanoma cells to inhibition of BRAF and/or MEK in both culture cells and xenograft mouse models.